Company record
Leading Pharma, LLC
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Leading Pharma, LLC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Apr 29 | Class II | Leading Pharma, LLC Drug |
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01 CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit. |